VistaGen Therapeutics Inc Q3 Loss Increases, But Beats Estimates

(RTTNews) - VistaGen Therapeutics Inc (VTGN) reported Loss for its third quarter that increased from last year but beat the Street estimates.

The company's earnings totaled -$14.09 million, or -$0.46 per share. This compares with -$6.35 million, or -$0.22 per share, last year.

Analysts on average had expected the company to earn -$0.52 per share. Analysts' estimates typically exclude special items.

The company's revenue for the period fell 43.9% to $0.23 million from $0.41 million last year.

VistaGen Therapeutics Inc earnings at a glance (GAAP) :

-Earnings: -$14.09 Mln. vs. -$6.35 Mln. last year. -EPS: -$0.46 vs. -$0.22 last year. -Revenue: $0.23 Mln vs. $0.41 Mln last year.